✦ LIBER ✦

A Randomized Study to Demonstrate Noninferiority of Once-Daily OROS® Hydromorphone with Twice-Daily Sustained-Release Oxycodone for Moderate to Severe Chronic Noncancer Pain

✍ Scribed by Heinrich Binsfeld; Leszek Szczepanski; Sandra Waechter; Ute Richarz; Rainer Sabatowski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sustained Safety and Efficacy of Once-Da

✍ Ute Richarz; Sandra Waechter; Rainer Sabatowski; Leszek Szczepanski; Heinrich Bi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

Safety and efficacy of once-daily hydrom

✍ U. Richarz; S. Waechter; R. Sabatowski; L. Szczepanski; H. Binsfeld 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Safety and Tolerability of Once-Daily OR

✍ Srinivas R. Nalamachu; Michael Kutch; Martin E. Hale 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 172 KB

(813): Oral once-a-day AVINZA (morphine

✍ R. Rauck; S. Bookbinder; T. Bunker; C. Alftine; A. Negro-Vilar; E. De Jong; S. G 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Randomized, multi-center study of oral o

✍ R. Rauck; S. Bookbinder; T. Bunker; C. Alftine; E. de Jong; S. Gershon 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Results of a Double-blind, Placebo-contr

✍ Richard Rauck; Ronald Rapoport; John Thipphawong 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB